Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Lipoamide-containing enzymes are a group of mitochondrial multi-enzyme complexes that utilize lipoic acid covalently attached to lysine residues as an essential prosthetic group. These include the pyruvate dehydrogenase complex, 2‑oxoglutarate dehydrogenase complex, branched-chain alpha-keto acid dehydrogenase complex, and the glycine cleavage system. Each contains one or more subunits that use lipoamide for catalyzing oxidative decarboxylation reactions central to energy metabolism—converting key metabolites into acetyl-CoA or succinyl-CoA while reducing NAD+ to NADH for ATP production. The best-characterized example is dihydrolipoamide dehydrogenase (DLD), which acts as the E3 component common across these complexes. Mutations affecting these enzymes can cause severe metabolic diseases due to impaired mitochondrial energy generation. Because “lipoamide-containing enzymes” refers collectively rather than individually, this entry is too broad for precise drug targeting without specifying which member is meant.
Catalysis of redox reactions involving transfer of acyl groups and electrons between substrates and coenzymes such as NAD+ and FAD
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lipoamide-containing enzyme.